Currie Harriss T received an award of 141,372 AdaptHealth Corp. shares on 2026-09-09, becoming the holder of 141,372 shares. For investors, the transaction represents about 100.0% of Harriss’s resulting AdaptHealth shareholding and establishes a new insider position for the company’s chief financial officer.
Key Highlights
- Currie Harriss T was awarded 141,372 AdaptHealth Corp. shares on 9 September 2026.
- The transaction was reported under SEC transaction code A.
- Following the transaction, Currie Harriss T owned 141,372 AdaptHealth shares.
Currie Harriss T received 141,372 shares of AdaptHealth Corp (NASDAQ: AHCO). on 9 September 2026, becoming the holder of 141,372 shares. Harriss is AdaptHealth’s chief financial officer.
141,372-Share Award and New Insider Position
Transaction code A identifies the event as an award or grant of shares. The award was made to Harriss in the role of chief financial officer at AdaptHealth Corp. Following the transaction, Harriss held 141,372 AdaptHealth shares. The reported award and resulting holding carry the same 141,372-share figure. The event is identified as a new insider position.
FAQs
Q: How many AdaptHealth shares did Currie Harriss T receive?
A: Currie Harriss T received 141,372 AdaptHealth Corp. shares on 9 September 2026. The transaction was classified under code A, meaning an award or grant.
Q: What was the resulting AdaptHealth shareholding?
A: Following the insider transaction, Currie Harriss T owned 141,372 AdaptHealth shares. The filing reports this as the resulting shareholding after the award, and Harriss serves as AdaptHealth Corp.’s chief financial officer.
Q: What percentage of Currie Harriss T’s holding did the award represent?
A: The award represented about 100.0% of Currie Harriss T’s resulting AdaptHealth shareholding. The filing reports this percentage based on the resulting shares holding after the transaction, which was identified as a new insider position.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.